Literature DB >> 21692558

Identification and functional studies of HLA-A0201 restricted CTL epitopes in the X protein of hepatitis B virus.

Y J Guo1, Y Zhu, S H Sun.   

Abstract

Cytotoxic T lymphocyte (CTL) epitopes in the X protein (HBx) of hepatitis B virus (HBV) may play a key role in the viral control and liver damage. The aim of this study was to identify and study the function of HLA-A0201 restricted CTL epitopes in HBx of HBV genotypes B and C that are epidemic in China. Four nonapeptides signed HBx1: VLCLRPVGA, HBx2: CLFKDWEEL, HBx3: VLHKRTLGL, and HBx4: HLSLRGLPV were predicated by computational analysis and manually confirmed by defining the peptide supermotif, extended motif, and quantitative motif. Synthesized peptides were examined for their affinity and binding stability with HLA-A0201. After being analyzed by enzyme-linked immunospot (ELISPOT) and cytolytic activity assays, the HBx2 epitope was selected for a construction of HLA-A0201-peptide tetramers. The tetramer staining method was used to analyze peripheral blood mononuclear cells (PBMCs) isolated from HBV-infected patients at different disease stages (chronic hepatitis, liver cirrhosis, and hepatoma). Compared with CTL epitopes in the HBV envelope or polymerase, HBx2 is also a potential HLA-A0201 restricted CTL epitope, what may have a clinical implication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21692558     DOI: 10.4149/av_2011_02_107

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  4 in total

1.  A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes.

Authors:  Lu Sun; Yu Zhang; Bao Zhao; Mengmeng Deng; Jun Liu; Xin Li; Junwei Hou; Mingming Gui; Shuijun Zhang; Xiaodong Li; George F Gao; Songdong Meng
Journal:  Protein Cell       Date:  2014-03-22       Impact factor: 14.870

2.  Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican‑3‑derived peptide.

Authors:  Yoshitaka Tada; Toshiaki Yoshikawa; Manami Shimomura; Yu Sawada; Mayuko Sakai; Hirofumi Shirakawa; Daisuke Nobuoka; Tetsuya Nakatsura
Journal:  Int J Oncol       Date:  2013-07-31       Impact factor: 5.650

Review 3.  A Systematic Review of T Cell Epitopes Defined from the Proteome of Hepatitis B Virus.

Authors:  Yandan Wu; Yan Ding; Chuanlai Shen
Journal:  Vaccines (Basel)       Date:  2022-02-08

4.  Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide.

Authors:  Tatsuaki Iwama; Kazutaka Horie; Toshiaki Yoshikawa; Daisuke Nobuoka; Manami Shimomura; Yu Sawada; Tetsuya Nakatsura
Journal:  Int J Oncol       Date:  2013-01-23       Impact factor: 5.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.